Pharmacotherapy for dyslipidaemia – current therapies and future agents

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.11, 2003-11, pp. : 1901-1938

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current, New and Future Treatments in Dyslipidaemia and Atherosclerosis

By Chong P.H.

Drugs, Vol. 60, Iss. 1, 2000-07 ,pp. : 55-93

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of postpartum depression: current practice and future directions

By Tcheremissine Oleg V Lieving Lori M

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. : 1999-2005

Informa Healthcare

Access to resources Recommend Favorite

Vitiligo: an update on current pharmacotherapy and future directions

By Colucci Roberta Lotti Torello Moretti Silvia

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 13, 2012-09 ,pp. : 1885-1899

Informa Healthcare

Access to resources Recommend Favorite

Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives

By Stevens Julie E Jones Karen L Rayner Christopher K Horowitz Michael

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1171-1186

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy of scleritis: current paradigms and future directions

By Beardsley Robert M Suhler Eric B Rosenbaum James T Lin Phoebe

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 4, 2013-03 ,pp. : 411-424

Informa Healthcare

Access to resources Recommend Favorite